Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....
View:
Post by Hiddensecrets on Jan 04, 2021 9:49pm

QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....

The PP of $ 5 million will pay down some debt therefore, QSC saves interest payments.

In addition QSC now has funds to quickly expand cubes without having to wait for insurance funds that take 60 days to 90 days.  

QSC also saves cost of financing receivables preferring to keep sale funds in its pockets.

In latest press release QSC said it was opening a cube and was paid the rent with 350 antigen tests per month given to the municipality.    This saved QSC money.

A common theme arises:         KEEP PROFIT MARGINS OF 55% AND INCREASE THEM.

If QSC has done factoring, then margins go down.   If QSC keeps debts on books, then interest eats into their dollars and, any money made cannot be used for growth but must be used to pay debts.

QSC prefers to GROW.

Canaccord could solve this delema for them but they wanted a deal.  Cost would be some dilution and shares at 25 cents.   In return QSC maintains HIGH PROFIT MARGINS and gets Cannacord to bring investors to QSC.

After reflection and putting emotions aside, THIS WAS A VERY SMART DECISION. 

We can now realistically expect 125 cubes by January 31st.

MPO
Comment by TotalCorruption on Jan 04, 2021 10:02pm
I agree QSC never needed pumping! I agree it needed financing. Cannacord will mess this up I believe in a nasty way. I totally believe in this biz & just have seen Cannacord at work for 35 years. Ugh. This been played with and I now feel I understand why. They are why. CEO should have chiselled out a way better deal. I'm obviously not happy lol. Biz is good enough to maybe foil their ...more  
Comment by wembley on Jan 04, 2021 10:08pm
You all have very short memories. Two weeks ago you could of bought as much as you wanted at .15 cents. Grow up boy You are lucky to involved.
Comment by CerealKiller on Jan 04, 2021 10:15pm
Hear! Hear!
Comment by TotalCorruption on Jan 04, 2021 10:16pm
Grow up! Who put it there? It never made sense!
Comment by CerealKiller on Jan 04, 2021 10:13pm
OK, I'm going to try one more time with you. Forget the past and possible manipulations from Canaccord to get a good price here. Moving forward, only moving forward, think about if it makes any sense at all for Canaccord to negatively manipulate the share price. Does that make sense? Of course not. So, when I said you were whining about the past, you may have had a right to, but it's ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities